JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details

113 * ! Mon, 7/30/2012, 8:30 AM - 10:20 AM CC-Room 23A
Dose Selection in Clinical Trials — Topic Contributed Papers
Biopharmaceutical Section , International Indian Statistical Association
Organizer(s): Weihua Cao, FDA
Chair(s): zhi wen, FDA
8:35 AM Simultaneous Inference for Dose Selection with Binary Responses Bernhard Klingenberg, Williams College
8:55 AM Utility-Based Dose-Finding in Phase I-II Clinical Trials Peter Thall, MD Anderson Cancer Center ; Hoang Q Nguyen, MD Anderson Cancer Center
9:15 AM Characterizing Dose-Response in the Development of Novel Treatments for Multiple Sclerosis David I Ohlssen, Novartis
9:35 AM Designing Phase 2 Trials Based on Program-Level Criteria Nitin Patel, Cytel Inc. ; James Bolognese, Cytel Inc. ; Christy Chuang-Stein, Pfizer Inc. ; David Hewitt, Merck ; Arnold Gammaitoni, Nuvo Research ; Jose Carlos Pinheiro, Johnson & Johnson
9:55 AM Discussant: Amelia Dale Horne, FDA
10:15 AM Floor Discussion

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.